from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv0189c/ilvD

LFCtreatmentdescriptionclass of inhibitor

-0.462

Amikacinug/mL Amikacintranslation

-0.956

Cap5-10ug/mL Capreomycintranslation

-1.705

Rox10-50 ug/mL Roxithromycintranslation

-0.476

SM2-5 ug/mL Streptomycintranslation

-1.484

Tet5-10 ug/mL Tetracyclinetranslation

-0.484

Rif0.2-5ug/mL Rifampicintranscription

-0.523

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.000

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

1.246

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.233

CPZ10-50 ug/mL Chlorpromazinerespiration

2.655

Clofazimine10-13 ug/mL Clofaziminerespiration

0.118

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

1.404

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

2.633

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-1.841

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.050

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.603

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.740

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

1.480

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.858

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

1.346

KCN5-20 ug/mL Potassium cyaniderespiration

0.799

NaN30.2-2 mM Sodium aziderespiration

-1.200

Nigericin50 uM Nigericinrespiration

0.227

TRC10-150 ug/mL Triclosanrespiration

1.430

TRZ10-25 ug/mL Thioridazinerespiration

-1.406

Valinomycin0.5-10 uM Valinomycinrespiration

0.620

ZnSO42 mM ZnSO4respiration

-0.135

menadione6-10 ug/mL Menadionerespiration

-0.486

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.152

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.136

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.789

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.118

NRP_1Non-replicating persistence stage 1dosRassociated

0.018

Amp0.2mg/mL AmpicillincellWall

0.739

Cephalexin20-100 ug/mL CephalexincellWall

0.316

Cerulenin0.32-5 ug/mL CerulenincellWall

0.031

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.673

EMB10-20 ug/mL EthambutolcellWall

1.039

Eta12-40 ug/mL EthionamidecellWall

1.347

INH0.2-0.4 ug/mL IsoniazidcellWall

0.586

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-3.771

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.000

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.100

BZA0.12 mg/mL BenzamidearomaticAmides

-0.490

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.188

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.637

H2O24 mM hydrogen peroxideDNAdamaging

-0.423

Levo10 ug/mL LevofloxacinDNAdamaging

-0.333

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

1.422

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.251

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.315

UVUV-irradiationDNAdamaging

1.442

ARP41-4 ug/mL Antitubercular compound ARP4?

0.125

Antimycin12.5-50 ug/mL Antimycin A?

-0.565

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.115

PA_110-50 ug/mL Antitubercular compound PA-1?

0.527

PA_2110-50 ug/mL Antitubercular compound PA-21?

0.061

PA8240.2-2 ug/mL PA-824?

0.108

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.603

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.365

Verapamil50 uM Verapamil?

-0.282

mercaptoethanol2 mM 2-Mercaptoethanol?

0.415

methoxatin10-20 ug/mL Methoxatin?